ATE380820T1 - Murine alpha(1,3)-fucosyltransferase (fuc-tvii) - Google Patents
Murine alpha(1,3)-fucosyltransferase (fuc-tvii)Info
- Publication number
- ATE380820T1 ATE380820T1 AT97908788T AT97908788T ATE380820T1 AT E380820 T1 ATE380820 T1 AT E380820T1 AT 97908788 T AT97908788 T AT 97908788T AT 97908788 T AT97908788 T AT 97908788T AT E380820 T1 ATE380820 T1 AT E380820T1
- Authority
- AT
- Austria
- Prior art keywords
- fucosyltransferase
- tvii
- fuc
- murine alpha
- murine
- Prior art date
Links
- 102100021333 Alpha-(1,3)-fucosyltransferase 7 Human genes 0.000 title abstract 2
- 101000819503 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 Proteins 0.000 title abstract 2
- 101001022183 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5 Proteins 0.000 title abstract 2
- 101001022175 Homo sapiens 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT6 Proteins 0.000 title abstract 2
- 101000862183 Homo sapiens Alpha-(1,3)-fucosyltransferase 10 Proteins 0.000 title abstract 2
- 101000862213 Homo sapiens Alpha-(1,3)-fucosyltransferase 11 Proteins 0.000 title abstract 2
- 101000819497 Homo sapiens Alpha-(1,3)-fucosyltransferase 7 Proteins 0.000 title abstract 2
- 241001529936 Murinae Species 0.000 title abstract 2
- NIGUVXFURDGQKZ-UQTBNESHSA-N alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-beta-D-GlcpNAc Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@]3(O[C@H]([C@H](NC(C)=O)[C@@H](O)C3)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O NIGUVXFURDGQKZ-UQTBNESHSA-N 0.000 abstract 1
- 210000000265 leukocyte Anatomy 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61309896A | 1996-03-08 | 1996-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE380820T1 true ATE380820T1 (de) | 2007-12-15 |
Family
ID=24455853
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97908788T ATE380820T1 (de) | 1996-03-08 | 1997-03-07 | Murine alpha(1,3)-fucosyltransferase (fuc-tvii) |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US6693183B2 (de) |
| EP (1) | EP0888377B1 (de) |
| JP (1) | JP2000507095A (de) |
| AT (1) | ATE380820T1 (de) |
| AU (1) | AU731261B2 (de) |
| DE (1) | DE69738368T2 (de) |
| WO (1) | WO1997032889A1 (de) |
Families Citing this family (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858752A (en) * | 1995-06-07 | 1999-01-12 | The General Hospital Corporation | Fucosyltransferase genes and uses thereof |
| US6605455B1 (en) | 1998-01-29 | 2003-08-12 | The Board Of Regsnts Of The University Of Oklahoma | Tyrosylprotein sulfotransferases and methods of use thereof |
| US6060295A (en) * | 1998-01-29 | 2000-05-09 | The Board Of Regents Of The University Of Oklahoma | Nucleic acids and expression systems encoding tyrosylprotein sulfo transferases |
| US7029890B2 (en) | 1998-01-29 | 2006-04-18 | Siwa Biotech Corporation | Tyrosylprotein sulfotransferases and methods of use thereof |
| US6207432B1 (en) | 1998-01-29 | 2001-03-27 | The Board Of Regents Of The University Of Oklahoma | Tyrosylprotein sulfotransferases and methods of use thereof |
| US6071732A (en) * | 1998-01-29 | 2000-06-06 | The Board Of Regents Of The University Of Oklahoma | Tyrosylprotein sulfotransferases, nucleic acids encoding tyrosylprotein sulfotransferases, and methods of use thereof |
| US6204016B1 (en) | 1998-01-29 | 2001-03-20 | The Board Of Regents Of The University Of Oklahoma | Tyrosylprotein sulfotransferases and methods of use thereof |
| US6713283B2 (en) | 1998-01-29 | 2004-03-30 | The Board Of Regents Of The University Of Oklahoma | Tyrosylprotein sulfotransferases |
| WO1999048926A1 (fr) * | 1998-03-24 | 1999-09-30 | Kyowa Hakko Kogyo Co., Ltd. | ANTICORPS DIRIGE CONTRE LA α1,3-FUCOSYLTRANSFERASE (Fuc-TVII) HUMAINE |
| AU2001263149A1 (en) * | 2000-05-12 | 2001-11-26 | Neose Technologies, Inc. | In vitro fucosylation recombinant glycopeptides |
| US7173003B2 (en) * | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| US8008252B2 (en) | 2001-10-10 | 2011-08-30 | Novo Nordisk A/S | Factor VII: remodeling and glycoconjugation of Factor VII |
| US7157277B2 (en) | 2001-11-28 | 2007-01-02 | Neose Technologies, Inc. | Factor VIII remodeling and glycoconjugation of Factor VIII |
| US7214660B2 (en) * | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
| MXPA04012496A (es) * | 2002-06-21 | 2005-09-12 | Novo Nordisk Healthcare Ag | Glicoformos del factor vii pegilados. |
| KR20060003862A (ko) * | 2003-03-14 | 2006-01-11 | 네오스 테크놀로지스, 인크. | 수용성분기폴리머 및 그 접합체 |
| US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
| EP2055189A1 (de) | 2003-04-09 | 2009-05-06 | Neose Technologies, Inc. | Glycopegylierungsverfahren und durch die Verfahren hergestellte Proteine/Peptide |
| AU2004240553A1 (en) * | 2003-05-09 | 2004-12-02 | Neose Technologies, Inc. | Compositions and methods for the preparation of human growth hormone glycosylation mutants |
| WO2005012484A2 (en) * | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
| US8633157B2 (en) * | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
| US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
| KR101237884B1 (ko) * | 2003-12-03 | 2013-02-27 | 바이오제너릭스 에이지 | 글리코 peg화 과립구 콜로니 자극인자 |
| US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
| US7338933B2 (en) * | 2004-01-08 | 2008-03-04 | Neose Technologies, Inc. | O-linked glycosylation of peptides |
| WO2006010143A2 (en) | 2004-07-13 | 2006-01-26 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 [glp-1] |
| WO2006020372A2 (en) * | 2004-07-23 | 2006-02-23 | Neose Technologies, Inc. | Enzymatic modification of glycopeptides |
| WO2006031811A2 (en) * | 2004-09-10 | 2006-03-23 | Neose Technologies, Inc. | Glycopegylated interferon alpha |
| US20080176790A1 (en) | 2004-10-29 | 2008-07-24 | Defrees Shawn | Remodeling and Glycopegylation of Fibroblast Growth Factor (Fgf) |
| US9029331B2 (en) * | 2005-01-10 | 2015-05-12 | Novo Nordisk A/S | Glycopegylated granulocyte colony stimulating factor |
| US20070154992A1 (en) | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| EP1891231A4 (de) | 2005-05-25 | 2011-06-22 | Novo Nordisk As | Glykopegylierter faktor ix |
| US20110003744A1 (en) * | 2005-05-25 | 2011-01-06 | Novo Nordisk A/S | Glycopegylated Erythropoietin Formulations |
| FI20055398A0 (fi) | 2005-07-08 | 2005-07-08 | Suomen Punainen Risti Veripalv | Menetelmä solupopulaatioiden evaluoimiseksi |
| US20070105755A1 (en) * | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
| WO2007056191A2 (en) | 2005-11-03 | 2007-05-18 | Neose Technologies, Inc. | Nucleotide sugar purification using membranes |
| ES2516694T3 (es) * | 2006-07-21 | 2014-10-31 | Ratiopharm Gmbh | Glicosilación de péptidos a través de secuencias de glicosilación con unión en O |
| US8969532B2 (en) * | 2006-10-03 | 2015-03-03 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography |
| US20100041872A1 (en) * | 2006-10-04 | 2010-02-18 | Defrees Shawn | Glycerol linked pegylated sugars and glycopeptides |
| KR20100016160A (ko) * | 2007-04-03 | 2010-02-12 | 바이오제너릭스 에이지 | 글리코페길화 ｇ―ｃｓｆ를 이용하는 치료 방법 |
| EP2162535A4 (de) * | 2007-06-04 | 2011-02-23 | Novo Nordisk As | O-verknüpfte glykosylierung unter verwendung von n-acetylglucosaminyl-transferasen |
| WO2008154639A2 (en) * | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Improved process for the production of nucleotide sugars |
| US8207112B2 (en) * | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
| CA2711503A1 (en) * | 2008-01-08 | 2009-07-16 | Biogenerix Ag | Glycoconjugation of polypeptides using oligosaccharyltransferases |
| KR101582841B1 (ko) | 2008-02-27 | 2016-01-11 | 노보 노르디스크 에이/에스 | 콘쥬게이트된 인자 ｖｉｉｉ 분자 |
| EP2166085A1 (de) | 2008-07-16 | 2010-03-24 | Suomen Punainen Risti Veripalvelu | Divalente modifizierte Zellen |
| SG178064A1 (en) * | 2009-07-21 | 2012-03-29 | Abt Holding Co | Use of stem cells to reduce leukocyte extravasation |
| EP2456860B1 (de) * | 2009-07-21 | 2018-09-05 | ABT Holding Company | Verwendung von stammzellen für reduzierte leukozyten-extravasation |
| US9692789B2 (en) | 2013-12-13 | 2017-06-27 | Oracle International Corporation | Techniques for cloud security monitoring and threat intelligence |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG49117A1 (en) * | 1993-03-29 | 1998-05-18 | Kyowa Hakko Kogyo Kk | Alfa -1, 3-fucosyltransferase |
| US5858752A (en) * | 1995-06-07 | 1999-01-12 | The General Hospital Corporation | Fucosyltransferase genes and uses thereof |
| US5858750A (en) * | 1997-11-25 | 1999-01-12 | Incyte Pharmaceuticals, Inc. | Human retinol dehydrogenase type II homolog |
-
1997
- 1997-03-07 WO PCT/US1997/003184 patent/WO1997032889A1/en not_active Ceased
- 1997-03-07 AT AT97908788T patent/ATE380820T1/de not_active IP Right Cessation
- 1997-03-07 EP EP97908788A patent/EP0888377B1/de not_active Expired - Lifetime
- 1997-03-07 AU AU20608/97A patent/AU731261B2/en not_active Ceased
- 1997-03-07 DE DE69738368T patent/DE69738368T2/de not_active Expired - Lifetime
- 1997-03-07 JP JP9531850A patent/JP2000507095A/ja not_active Ceased
-
2001
- 2001-02-16 US US09/784,077 patent/US6693183B2/en not_active Expired - Lifetime
-
2003
- 2003-11-05 US US10/700,505 patent/US7723080B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69738368D1 (de) | 2008-01-24 |
| DE69738368T2 (de) | 2008-12-04 |
| JP2000507095A (ja) | 2000-06-13 |
| EP0888377A4 (de) | 2001-12-05 |
| EP0888377A1 (de) | 1999-01-07 |
| US6693183B2 (en) | 2004-02-17 |
| AU2060897A (en) | 1997-09-22 |
| US7723080B2 (en) | 2010-05-25 |
| WO1997032889A1 (en) | 1997-09-12 |
| AU731261B2 (en) | 2001-03-29 |
| US20020111469A1 (en) | 2002-08-15 |
| US20040063178A1 (en) | 2004-04-01 |
| EP0888377B1 (de) | 2007-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE380820T1 (de) | Murine alpha(1,3)-fucosyltransferase (fuc-tvii) | |
| HUP0202759A2 (hu) | Táptalaj sejtek fehérjementes és szérummentes tenyésztéséhez | |
| CA2167521A1 (en) | Compositions and methods for producing sialyltransferases | |
| DK0960109T3 (da) | Fremgangsmåde til fremstilling af tolterodin | |
| AP9400666A0 (en) | Benzofuran derivatives. | |
| AU6226198A (en) | Improved methods of making cross-bridged macropolycycles | |
| ITTO940751A0 (it) | Procedimento per la produzione di carburo di ferro. | |
| NO943323L (no) | Sammensetninger og fremgangsmåte for identifisering og syntese av sialyltransferaser | |
| BG102016A (en) | Method for the diagnostics of schizophrenia | |
| MY110619A (en) | Ring-substituted 2-amino-1, 2,3, 4-tetra-hydronaphthalenes, 3-aminochromanes, and 3-aminothiochromanes. | |
| AU4823993A (en) | Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof | |
| EP0733709A3 (de) | Mutierte Farnesyldiphosphatesynthase befähigt zum Synthetisieren von Geranylgeranyldiphosphat und dafür kodierende Gene | |
| CY1116418T1 (el) | Διεργασια για την παραγωγη r-(+)-6-καρβοξαμιδο-3-ν-μεθυλαμινο-1,2,3,4-τετραϋδροκαρβαζολιου | |
| BG108682A (en) | Method for the production of transparent flexible container, and container produced therewith | |
| MY106522A (en) | Arylaminocarbonyl compounds. | |
| MY131172A (en) | 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd) indoles | |
| AU1170501A (en) | Cubic boron nitride clusters | |
| IL139773A0 (en) | Morphine-6-glucuronide synthesis | |
| GB2341391B (en) | Cloning of UDP-galactose epimerase | |
| GB2325466A (en) | Nucleotide sequence from goat liver | |
| DE69637429D1 (de) | Gene, die für lymphocyte spezifischen interferon-regulationsfaktor (lsirf) polypeptide kodiert | |
| CA2247966A1 (en) | Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof | |
| AU2455600A (en) | Apoptosis-inducing factor | |
| AU5369399A (en) | Basic refractory ceramic hollow body | |
| CA2281226A1 (en) | Process for synthesizing .alpha.-substituted ring systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |